Mary Busowski, MD
Hospice and Palliative Medicine · Orlando, FLNPI 1801871769
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $103, 8.9 times the $12 reported in 2019.
Across 8 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$32
- Takeda Pharmaceuticals U.S.A., Inc.$26
- AstraZeneca$25
- Daiichi Sankyo Inc.$23
- Eisai Inc.$20
- Johnson & Johnson$20
- plus $26 from 2 others
What the payments were for
- Food & beverage$173100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| AstraZeneca | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Genentech USA, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$173 in reported general payments places this provider in the 65th percentile of 177 hospice and palliative medicine providers in Florida.
See all hospice and palliative medicine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 29 | $20,924 |
| OxycontinOxycodone Hcl | 16 | $13,819 |
| Hydromorphone Hcl | 30 | $9,531 |
| Oxycodone Hcl | 188 | $7,283 |
| Morphine Sulfate ErMorphine Sulfate | 83 | $3,596 |
| Morphine Sulfate | 35 | $1,853 |
| Gabapentin | 83 | $973 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $965 |
| Ondansetron OdtOndansetron | 13 | $778 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $551 |
| Duloxetine Hcl | 37 | $530 |
| Methadone Hcl | 21 | $201 |
| Pregabalin | 11 | $164 |
| Mirtazapine | 12 | $124 |
| Alprazolam | 17 | $81 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Orlando
- Tanveer MirOrlando$1K
- Ferdinand Melendez PadillaOrlando$218
- Laurence PettyPlant City$140K
- Michael KaragiozisTemple Terrace$21K
- Young Doo ChangTampa$10K
- Joshua SmithTampa$7K
- Sharon Nickell-OlmEustis$3K
- Lidia OliveiraLake Mary$2K
- William BerkeNorth Miami Beach$2K
- Anthony DardanoBoca Raton$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.